Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-23 Sale |
2024-09-25 8:54 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
2,000 | $99.6 | $199,201 | 93,478 (Direct) |
View |
| 2024-08-28 Sale |
2024-08-30 8:56 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
1,500 | $106.39 | $159,591 | 83,978 (Direct) |
View |
| 2024-05-09 Sale |
2024-05-13 5:32 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $83.04 | $830,449 | 85,149 (Direct) |
View |
| 2023-03-24 Sale |
2023-03-28 5:00 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
300 | $69.92 | $20,977 | 16,308 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 6:55 pm |
N/A 2035-03-04 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
34,458 | $0 | 62,826 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
12,357 | $0 | 28,368 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 8:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
6,523 | $120 | 28,368 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-25 8:54 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
2,000 | $52.27 | 93,478 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-25 8:54 pm |
N/A 2032-08-01 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
2,000 | $0 | 93,478 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 8:56 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
1,500 | $52.27 | 83,978 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-30 8:56 pm |
N/A 2032-08-01 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary |
1,500 | $0 | 83,978 (Direct) |
View |
| 2024-06-28 Other |
2024-07-02 7:45 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
329 | $60.71 | 22,863 (Direct) |
View |
| 2024-05-09 Exercise |
2024-05-13 5:32 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $52.27 | 85,149 (Direct) |
View |
| 2024-05-09 Exercise |
2024-05-13 5:32 pm |
N/A 2032-08-01 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $0 | 85,149 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
36,480 | $0 | 51,477 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
593 | $74.65 | 14,997 (Direct) |
View |
| 2023-12-29 Other |
2024-01-04 4:07 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
179 | $60.71 | 15,769 (Direct) |
View |
| 2023-08-10 Tax Withholding |
2023-08-14 4:20 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
897 | $68.73 | 15,411 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:51 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
21,061 | $0 | 32,001 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:39 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
1,073 | $72.9 | 10,940 (Direct) |
View |
Ownership |
2022-11-07 8:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
0 | $0 | 84,957 (Direct) |
View |